Related Experiment Videos
Thalidomide's tightly controlled "comeback"
1Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, USA.
Cleveland Clinic Journal of Medicine
|March 18, 1999
Abstract:
Thalidomide has anti-inflammatory properties and shows promise for treating a variety of infectious and autoimmune diseases, but it must be used with strict precautions.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?
Pathogens & immunity·2021
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Menstrual Abnormalities, Nutritional Patterns, and Body Composition in Female Classical Ballet Dancers.
The Physician and sportsmedicine·2016
AIDS and Athletes.
The Physician and sportsmedicine·2016
HIV and Sports: What Is the Risk?
The Physician and sportsmedicine·2016
Actinic keratosis: A clinician's guide to diagnosis and treatment.
Cleveland Clinic journal of medicine·2026
MASLD and MASH: Steatotic liver disease joins the deadly quartet.
Cleveland Clinic journal of medicine·2026
Kratom at a crossroads: Trends, controversies, and the evidence gap.
Cleveland Clinic journal of medicine·2026
Navigating pulmonary nodules: Guidelines on assessing risk and determining next steps in primary care.
Cleveland Clinic journal of medicine·2026
Winning the battle against Barrett esophagus and esophageal adenocarcinoma.
Cleveland Clinic journal of medicine·2026
Isolated atrial amyloidosis from atrial natriuretic peptide - a common but overlooked cardiac condition.
Upsala journal of medical sciences·2026
Epigenetic reprogramming in autoimmune and immune-mediated skin disease.
Frontiers in immunology·2026